Skip to content
glp1.howSign in

Talking to your doctor about switching GLP-1 medications

Not every GLP-1 works equally well for every person. How to raise a switch to a different drug, dose, or formulation with your prescriber, and what to ask about titration and coverage.

Updated Sep 26, 2026

If your current GLP-1 isn't working for you, switching is a normal thing to raise with your prescriber. Maybe your results have stalled, the side effects won't settle, or you're curious about a newer drug. The conversation goes best when you bring specifics.

Why you might consider switching

People respond differently to the same GLP-1 medication. A plateau, side effects that persist, or wanting to try a dual agonist after starting on a single-pathway drug are all fair reasons to ask. Our guide on what the data say about super responders explains how much individual response varies.

How to frame the conversation

Instead of asking "is there something else I could try?", tell your prescriber how long you've been on the current medication and dose, what results you've seen (or haven't), and which side effects you've had and how bad they are. If you've hit a weight loss plateau, say so. Plateaus are common, and your prescriber will have a way of handling them that may or may not involve a new drug. (See does increasing your dose always mean more weight loss? for why a higher dose isn't always the first move.)

Questions to ask

  • "Is my lack of progress typical, or does it suggest this medication isn't working well for me?"
  • "If we switch, do we need a washout period, or can I transition directly?"
  • "Will the new drug need its own prior authorization, and is it on my plan's formulary?" Coverage and prior authorization are decided drug by drug, so don't assume approval for one GLP-1 carries over to another.
  • "What side effects should I expect during the transition?"

What to expect after a switch

Expert guidance on switching between GLP-1 medications (Jain et al., International Journal of Clinical Practice) recommends starting the new drug based on your prior dose and how long you took it, then titrating up slowly to limit GI side effects. For many people that means a lower starting dose and a new adjustment period, so don't expect your old results to pick up where they left off right away. A switch can also change your coverage; read our guide on understanding insurance coverage before treating it as a simple swap.

Study findings above are attributed to their authors and were located via PubMed.

This is peer information, not medical advice. Your clinician knows your full picture — use these prompts to start the conversation, not to replace it.

doctorswitching-medicationsconversations

Was this helpful?

Common questions

Questions people often ask about this topic.

  • When is it reasonable to ask about switching GLP-1 medications?

    People respond differently to the same GLP-1, so a plateau, side effects that persist, or wanting to try a dual agonist after starting on a single-pathway drug are all fair reasons to bring up a switch. It's a common conversation, and it goes better when you come prepared with specifics.

  • How should I prepare for a conversation about switching?

    Bring specifics: how long you've been on the current medication and dose, what results you've seen or haven't, and any side effects and how bad they are. If you've hit a weight loss plateau, say so. Plateaus are common, and your prescriber will have a way of handling them that may or may not involve switching drugs.

  • Will I have to start over at a low dose if I switch medications?

    Possibly. Expert switching guidance recommends choosing the new drug's starting dose based on your prior dose and how long you took it, then titrating up slowly to limit GI side effects. That often means a lower dose and a new adjustment period, so don't expect your previous results to continue right away. Ask your prescriber about this, and about whether a washout period is needed.

  • Can switching GLP-1 medications affect my insurance coverage?

    It can. Coverage and prior authorization are decided drug by drug, so a new medication may need its own approval and may not be on your plan's formulary, even if your current GLP-1 is covered. Ask about both the clinical and the coverage side before treating a switch as a simple swap.

Evidence: For & Against

Both sides of the topic, so you can weigh the evidence yourself.

2Supporting

Revision history

Last updated · 3 revisions recorded.

Show what changed
  1. v3

    Common questions revised

  2. v2

    Summary rewritten; Body revised

  3. v1

    Existing article recorded at the start of version history

Improve this page

Community notes

Share helpful experiences and questions. Notes are reviewed before publication and do not replace medical advice.

Loading notes…

    New submissions are currently paused. Existing approved notes remain available.

    Related terms

    • Hazard ratio — A statistic from clinical trials that compares how often an event happens over time in one group versus another; below 1 means a lower rate in the treated group.
    • Sharps container — A puncture-resistant container for safely collecting used needles, pen needles, and syringes until they can be disposed of according to local rules.
    • Oral semaglutide — Semaglutide taken as a once-daily pill instead of a weekly injection: Rybelsus and its reformulation, Ozempic tablets, for type 2 diabetes, and the Wegovy pill for weight management.

    Related guides

    • Gastric emptying on a GLP-1: how much slower, how long it lasts, and what it means for gastroparesis — GLP-1 medications slow the stomach, but the trials show the effect is smaller and fades more than most people assume, especially with the long-acting weekly drugs. This guide covers how much slower, whether it lasts, how gastric emptying is measured, how it differs from gastroparesis, and why the "food ferments in your stomach" claim has no evidence behind it.
    • Restarting a GLP-1 after a missed stretch: what each drug's label says about re-titration — Missed a few weeks of Wegovy, Zepbound, Ozempic, Trulicity, Saxenda, or a GLP-1 pill? Only four labels spell out when to restart at a lower dose: Wegovy injection after 2 missed weekly doses, Saxenda and Victoza after more than 3 days, and Foundayo after 7 missed daily doses. The rest are silent on long gaps. This by-drug reference separates what each label says from what's left to your prescriber, and explains why going straight back to your old dose is risky.
    • Comparing the GLP-1 pills: Ozempic tablets (Rybelsus), the Wegovy pill, and Foundayo — There are now three GLP-1 pills in the US, and they aren't interchangeable: oral semaglutide for diabetes (Rybelsus, now sold as Ozempic tablets), oral semaglutide for weight (the Wegovy pill), and orforglipron (Foundayo). Here's how they compare on approval, how you take them, what the trials found, side effects, cost, and what you give up versus a weekly injection.